Daniel MarkgrafHead of Laboratory, Cardio-Renal-Metabolic Disease Research at Boehringer IngelheimSpeaker
Agenda Sessions
Keynote Panel: Crafting Industry Collaborations – The Pharma Perspective
, 09:50View SessionBeyond GLP-1: Novel Strategies to enhance energy expenditure in obesity treatment
, 16:35View Session